Sanford J. Madigan
Amministratore Delegato presso Ankasa Regenerative Therapeutics, Inc.
Profilo
Sanford J.
Madigan is the founder of Silarus Therapeutics, Inc. (founded in 2014).
Dr. Madigan was also the founder of Strategic Enzyme Applications, Inc., Ankasa Regenerative Therapeutics, Inc., CadheRx Therapeutics, Inc., Nerio Therapeutics, Inc., and Anexigen, Inc. Dr. Madigan's current job(s) included being the Chief Executive Officer at Calporta Therapeutics, Inc. since 2018 and holding the position of President, Chief Operating Officer & Director at Sova Pharmaceuticals, Inc.Dr. Madigan's former job(s) included being the Director of Business Development at Sibia Neurosciences, Inc., Director at AnaptysBio, Inc., Vice President of Corporate Development at Ambit Biosciences Corp., Senior Manager at Xenopharm, Inc., Vice President of Corporate Development at Nereus Pharmaceuticals, Inc., and Vice President of Corporate Development & Strategic Planning at X-Ceptor Therapeutics, Inc.Dr. Madigan's education history included undergraduate and doctorate degrees from Stony Brook University.
Posizioni attive di Sanford J. Madigan
Società | Posizione | Inizio |
---|---|---|
Sova Pharmaceuticals, Inc.
Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | Presidente | - |
Ankasa Regenerative Therapeutics, Inc.
Ankasa Regenerative Therapeutics, Inc. Medical/Nursing ServicesHealth Services Ankasa Regenerative Therapeutic, Inc. operates as a biopharmaceutical company. It develops strategies to improve tissue healing by exploiting the potential of stem cell reactivation. The firm develops a proprietary formulations of a potent WNT stem cell activator with the potential to accelerate tissue healing in a broad range of degenerative conditions affecting bone, cartilage, skin, muscle, vasculature, and the central nervous system. The company was founded on September 9, 2014 and is headquartered in La Jolla, CA. | Amministratore Delegato | - |
CadheRx Therapeutics, Inc.
CadheRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology CadheRx Therapeutics, Inc. develops therapeutic antibodies for the treatment of solid tumors. The firm's soluble E-cadherin (sEcad) levels are increased in many epithelial cancers and result in increased tumor cell proliferation, migration, invasion and angiogenesis. The company was founded by Sandy J. Madigan and is headquartered in La Jolla, CA. | Fondatore | - |
Calporta Therapeutics, Inc.
Calporta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calporta Therapeutics, Inc. engages in developing small molecule agonists. It develops selective small molecule agonists of TRPML1 (transient receptor potential cation channel, mucolipin subfamily, member 1) for the treatment of Niemann-Pick C Disease (NPC) and other lysosomal storage diseases. The company was founded by Haoxing Xu and is headquartered in La Jolla, CA. | Amministratore Delegato | 01/01/2018 |
Nerio Therapeutics, Inc.
Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA. | Fondatore | - |
Anexigen, Inc.
Anexigen, Inc. BiotechnologyHealth Technology Anexigen, Inc. is a biotechnology company developing novel methods and compositions to combat existing and burgeoning antimicrobial threats. The company was founded by Sanford Madigan and Sergio Duron and is headquartered in La Jolla, CA. | Amministratore Delegato | - |
Precedenti posizioni note di Sanford J. Madigan
Società | Posizione | Fine |
---|---|---|
Silarus Therapeutics, Inc.
Silarus Therapeutics, Inc. BiotechnologyHealth Technology Silarus Therapeutics, Inc. develops therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. The company was founded by Tomas Ganz, Sanford J. Madigan, and Elizabeta Nemeth in May 19, 2014 and is headquartered in La Jolla, CA. | Fondatore | - |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services X-Ceptor is a privately held biopharmaceutical company focusing on research in the rapidly developing field of orphan nuclear receptors that serve as the molecular targets for the discovery of novel small molecule pharmaceutical products for the treatment of human diseases. X-Ceptor has developed an integrated approach to drug discovery drawing from their in-house expertise in biology, chemistry and high-throughput screening. X-Ceptor's advantage lies in its understanding of orphan nuclear receptors and their signaling pathways, as well as its proprietary ability to employ these orphan nuclear receptors in transcriptional and biochemical based assays to discover novel therapeutic agents | Corporate Officer/Principal | - |
AMBIT BIOSCIENCES CORP | Corporate Officer/Principal | - |
░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Sanford J. Madigan
Stony Brook University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ANAPTYSBIO, INC. | Health Technology |
Aziende private | 13 |
---|---|
Sibia Neurosciences, Inc. | Health Technology |
Ambit Biosciences Corp.
Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Xenopharm, Inc.
Xenopharm, Inc. Miscellaneous Commercial ServicesCommercial Services Xenopharm, Inc. develops drug sensing molecules. The company was founded by Ronald M. Evans and is headquartered in Sam Mateo, CA. | Commercial Services |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Commercial Services |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services X-Ceptor is a privately held biopharmaceutical company focusing on research in the rapidly developing field of orphan nuclear receptors that serve as the molecular targets for the discovery of novel small molecule pharmaceutical products for the treatment of human diseases. X-Ceptor has developed an integrated approach to drug discovery drawing from their in-house expertise in biology, chemistry and high-throughput screening. X-Ceptor's advantage lies in its understanding of orphan nuclear receptors and their signaling pathways, as well as its proprietary ability to employ these orphan nuclear receptors in transcriptional and biochemical based assays to discover novel therapeutic agents | Commercial Services |
Sova Pharmaceuticals, Inc.
Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | Health Technology |
Strategic Enzyme Applications, Inc.
Strategic Enzyme Applications, Inc. Chemicals: SpecialtyProcess Industries Strategic Enzyme Applications, Inc. engaged in organic chemical manufacturer company. The company was headquartered in San Diego, CA. | Process Industries |
Ankasa Regenerative Therapeutics, Inc.
Ankasa Regenerative Therapeutics, Inc. Medical/Nursing ServicesHealth Services Ankasa Regenerative Therapeutic, Inc. operates as a biopharmaceutical company. It develops strategies to improve tissue healing by exploiting the potential of stem cell reactivation. The firm develops a proprietary formulations of a potent WNT stem cell activator with the potential to accelerate tissue healing in a broad range of degenerative conditions affecting bone, cartilage, skin, muscle, vasculature, and the central nervous system. The company was founded on September 9, 2014 and is headquartered in La Jolla, CA. | Health Services |
CadheRx Therapeutics, Inc.
CadheRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology CadheRx Therapeutics, Inc. develops therapeutic antibodies for the treatment of solid tumors. The firm's soluble E-cadherin (sEcad) levels are increased in many epithelial cancers and result in increased tumor cell proliferation, migration, invasion and angiogenesis. The company was founded by Sandy J. Madigan and is headquartered in La Jolla, CA. | Health Technology |
Calporta Therapeutics, Inc.
Calporta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calporta Therapeutics, Inc. engages in developing small molecule agonists. It develops selective small molecule agonists of TRPML1 (transient receptor potential cation channel, mucolipin subfamily, member 1) for the treatment of Niemann-Pick C Disease (NPC) and other lysosomal storage diseases. The company was founded by Haoxing Xu and is headquartered in La Jolla, CA. | Health Technology |
Nerio Therapeutics, Inc.
Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA. | Commercial Services |
Anexigen, Inc.
Anexigen, Inc. BiotechnologyHealth Technology Anexigen, Inc. is a biotechnology company developing novel methods and compositions to combat existing and burgeoning antimicrobial threats. The company was founded by Sanford Madigan and Sergio Duron and is headquartered in La Jolla, CA. | Health Technology |
Silarus Therapeutics, Inc.
Silarus Therapeutics, Inc. BiotechnologyHealth Technology Silarus Therapeutics, Inc. develops therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. The company was founded by Tomas Ganz, Sanford J. Madigan, and Elizabeta Nemeth in May 19, 2014 and is headquartered in La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- Sanford J. Madigan